Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KOSDAQ/068760 stock hub

KOSDAQ/068760 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/068760is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.4T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/068760
In the news

Latest news · KOSDAQ/068760

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/E92.1
P25 12P50 23.1P75 39.5
ROE8.9
P25 -17.1P50 0.7P75 8.5
ROIC6.3
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/068760 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
217
Groups with data
11
Currency
KRW
Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

17
MetricValue
Country
South Korea
Country code
KR
Employees
328
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7068760008
Last refreshed
2026-05-10
Market cap
KRW 2.4T
Price
KRW 53,700
Price currency
KRW
Rev Per Employee
837,593,306.83x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/068760
Website
https://www.celltrionph.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
1.1%
FCF yield
-0.09%
P/B ratio
7.84x
P/E ratio
92.05x
P/S ratio
8.64x
PE Ratio10 Y
191.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
10.51%
EBITDA Margin
15.58%
Gross margin
29.43%
Gross Profit
KRW 80.8B
Gross Profit Growth
20.24%
Gross Profit Growth Q
47.31%
Gross Profit Growth3 Y
10.8%
Gross Profit Growth5 Y
10.88%
Net Income
KRW 26B
Net Income Growth
146.81%
Net Income Growth Q
228.36%
Net Income Growth Quarters
6%
Net Income Growth Years
2%
Net Income Growth3 Y
76.42%
Pretax Margin
9.16%
Profit Margin
9.47%
Profit Per Employee
KRW 79.3M
Profitable Years
7
ROA
3.41
Roa5y
0.86
ROCE
7.92
ROE
8.91
Roe5y
0.7
ROIC
6.25
Roic5y
1.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr10y
13.68%
Cagr15y
10.99%
Cagr1y
14.49%
Cagr20y
10.01%
Cagr3y
-9.6%
Cagr5y
-13.05%
EPS Growth
146
EPS Growth Q
226.2
EPS Growth Quarters
6
EPS Growth Years
2
EPS Growth3 Y
75.76
FCF Growth Q
82.58%
OCF Growth
-41.05%
OCF Growth Q
-40.49%
OCF Growth10 Y
25%
OCF Growth3 Y
136.38%
Revenue Growth
53.21x
Revenue Growth Q
92.73x
Revenue Growth Quarters
9x
Revenue Growth Years
3x
Revenue Growth3 Y
24.9x
Revenue Growth5 Y
29.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.52
Assets
KRW 572.9B
Cash
KRW 34.6B
Current Assets
KRW 257.2B
Current Liabilities
KRW 208.3B
Debt
KRW 191.8B
Debt EBITDA
KRW 4.48
Debt Equity
KRW 0.63
Debt FCF
KRW -87.93
Equity
KRW 302.8B
Interest Coverage
6.22
Liabilities
KRW 270.1B
Long Term Assets
KRW 315.7B
Long Term Liabilities
KRW 61.9B
Net Cash
KRW -157.1B
Net Cash By Market Cap
KRW -6.62
Net Debt EBITDA
KRW 3.67
Net Debt Equity
KRW 0.52
Tangible Book Value
KRW 267.7B
Tangible Book Value Per Share
KRW 6,038
WACC
9.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.23
Inventory Turnover
4.2
Net Working Capital
KRW 150B
Quick ratio
0.92
Working Capital
KRW 48.9B
Working Capital Turnover
KRW 6.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
-0.23%
Dividend Growth
0%
Dividend Growth Years
2%
Dividend per share
KRW 200
Dividend Years
1
Dividend Yield
0.37%
Ex Div Date
2025-12-29
Last Dividend
KRW 200

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
260.46%
1Y total return
14.48%
200-day SMA
58,985.3
3Y total return
-26.12%
50-day SMA
59,120
50-day SMA vs 200-day SMA
50over200
5Y total return
-50.29%
All Time High
221,035.5
All Time High Change
-75.71%
All Time High Date
2020-12-28
All Time Low
2,770.5
All Time Low Change
1,838.25%
All Time Low Date
2008-12-08
ATR
1,727.9
Beta
1.08
Beta1y
0.72
Beta2y
0.61
Ch YTD
-7.41
High
55,200
High52
78,300
High52 Date
2026-02-24
High52ch
-31.42%
Low
53,500
Low52
44,902
Low52 Date
2025-05-23
Low52ch
19.59%
Ma50ch
-9.17%
Price vs 200-day SMA
-8.96%
RSI
34.56
RSI Monthly
44.71
RSI Weekly
40.46
Sharpe ratio
0.4x
Sortino ratio
0.76
Total Return
0.15%
Tr YTD
-7.41
Tr15y
378.13%
Tr1m
-1.83%
Tr1w
-3.42%
Tr3m
-21.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
KRW 28.9B
Operating Income Growth
67.02
Operating Income Growth Q
119.8
Operating Income Growth3 Y
38.06
Operating margin
10.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
19,663,996%
Net Borrowing
23,740,304,060
Shares Insiders
0.17%
Shares Institutions
3.44%
Shares Out
44,214,461
Shares Qo Q
-0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
KRW -2.9B
Average Volume
80,023.45x
Bv Per Share
6,829.2
CAPEX
KRW -30.6B
Ch10y
259.3
Ch15y
376.6
Ch1m
-1.83
Ch1w
-3.42
Ch1y
14.11
Ch20y
561.4
Ch3m
-21.15
Ch3y
-26.36
Ch5y
-50.45
Ch6m
-11.8
Change
-2.19%
Change From Open
-2.54
Close
54,900
Days Gap
0.36
Depreciation Amortization
13,911,091,000
Dollar Volume
5,756,586,300
EBIT
KRW 28.9B
EBITDA
KRW 42.8B
EPS
KRW 583
F Score
6
FCF
KRW -2.2B
FCF Per Share
KRW -49.32
Financing CF
17,047,568,920
Fiscal Year End
December
Founded
1,976
Goodwill
32,912,453,000
Graham Number
9467.65973
Graham Upside
-82.37
Income Tax
KRW -874M
Investing CF
-40,652,927,390
Is Primary Listing
1
Last Report Date
2021-03-31
Last Split Date
2025-12-29
Last Split Type
Forward
Lynch Fair Value
KRW 14,584
Lynch Upside
-72.84
Ma150
61,176.5
Ma150ch
-12.22%
Ma20
56,720
Ma20ch
-5.32%
Net CF
4,832,922,230
Open
55,100
P OCF Ratio
83.5
Payment Date
2026-04-17
Position In Range
11.76
Ppne
247,137,239,140
Price Date
2026-05-08
Price EBITDA
KRW 55.48
Ptbv Ratio
8.87
Relative Volume
1.34x
Revenue
274,730,604,640x
SBC By Revenue
0.28x
Share Based Comp
767,156,000
Tax By Revenue
-0.32x
Tr20y
573.5%
Tr6m
-11.51%
Volume
107,199
Z Score
11.76
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/068760 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.4%
$200 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
2 consecutive years of growth
Total shareholder yield
+0.1%
Next ex-dividend date: 2025-12-29
Performance

KOSDAQ/068760 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+14.5%
S&P 500 1Y: n/a
3Y total return
-26.1%
S&P 500 3Y: n/a
5Y total return
-50.3%
S&P 500 5Y: n/a
10Y total return
+260.5%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/068760?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.4%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

KOSDAQ/068760 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
34.6
Neutral momentum band
Price vs 200-day MA
-9.0%
50/200-day relationship not available
Beta (5Y)
1.08
Moves roughly with the market
Sharpe ratio
0.40
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/068760

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/068760 stock rating?

kosdaq/068760 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/068760 analysis?

The full report lives at /stocks/kosdaq/068760/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/068760?

The latest report frames kosdaq/068760 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/068760 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.